Balance Sheet
Cash Flow Statement
AmortizationOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Other Working Capital Changes (2016 - 2022)

Historic Other Working Capital Changes for RedHill Biopharma (RDHL) over the last 12 years, with Q1 2022 value amounting to $1.2 million.

  • RedHill Biopharma's Other Working Capital Changes fell 1918.77% to $1.2 million in Q1 2022 from the same period last year, while for Mar 2022 it was $287000.0, marking a year-over-year increase of 11480.14%. This contributed to the annual value of $1.7 million for FY2024, which is 699.87% up from last year.
  • Per RedHill Biopharma's latest filing, its Other Working Capital Changes stood at $1.2 million for Q1 2022, which was down 1918.77% from $1.4 million recorded in Q1 2021.
  • RedHill Biopharma's 5-year Other Working Capital Changes high stood at $1.4 million for Q1 2021, and its period low was -$3.3 million during Q2 2020.
  • Over the past 5 years, RedHill Biopharma's median Other Working Capital Changes value was $971000.0 (recorded in 2020), while the average stood at $159857.1.
  • Within the past 5 years, the most significant YoY rise in RedHill Biopharma's Other Working Capital Changes was 5339.65% (2020), while the steepest drop was 20466.42% (2020).
  • RedHill Biopharma's Other Working Capital Changes (Quarter) stood at $1.3 million in 2018, then plummeted by 184.34% to -$1.1 million in 2019, then crashed by 204.66% to -$3.3 million in 2020, then soared by 143.72% to $1.4 million in 2021, then dropped by 19.19% to $1.2 million in 2022.
  • Its last three reported values are $1.2 million in Q1 2022, $1.4 million for Q1 2021, and -$3.3 million during Q2 2020.